Attached files

file filename
EX-99.1 - NEWS RELEASE DATED DECEMBER 8, 2014 - MEDICUS HOMECARE INC.exhibit991.htm



 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)

December 5, 2014  



OVERTECH CORP.

(Exact name of registrant as specified in its charter)



NEVADA

333 -191251

None

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

 

Waiblingerstrasse 34

Stuttgart, Germany

 

70372

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant's telephone number, including area code

+49 157 894 69537


Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[   ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


[   ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


[   ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))


[   ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







ITEM 7.01

REGULATION FD DISCLOSURE


On December 5, 2014, the Board of Directors of Overtech Corp. (the "Company") approved a private placement offering of up to 2,400,000 shares of the Company's common stock at a price of USD$1.25 per share to persons who are not “U.S. Persons” as defined in Regulation S of the Securities Act of 1933, as amended.


There is no assurance that the private placement offering or any part of it will be completed.


The above does not constitute an offer to sell or a solicitation of an offer to buy any of the Company’s securities in the United States. The securities have not been registered under the United States Securities Act of 1933, as amended and may not be offered or sold within the United States or to U.S. persons unless an exemption from such registration is available.


This information is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. By filing this report on Form 8-K and furnishing this information, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.



SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

(d)

Exhibits


Exhibit Number

Description of Exhibit

99.1

News Release dated December 8, 2014.




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OVERTECH CORP.

Date: December 8, 2014

 

By:

/s/ Dr. Orhan Karahodza

 

 

Dr. Orhan Karahodza

Chief Executive Officer, President,

Secretary, Treasurer & Director




2